Moderna says its COVID-19 vaccine is effective in teenagers

The company will seek FDA approval next month.

Sean Keane Former Senior Writer
Sean knows far too much about Marvel, DC and Star Wars, and poured this knowledge into recaps and explainers on CNET. He also worked on breaking news, with a passion for tech, video game and culture.
Expertise Culture, Video Games, Breaking News
Sean Keane

Moderna seeks to expand the use of its vaccine.

Natalie Weinstein/CNET

Moderna's coronavirus vaccine is effective in 12- to 17-year-olds, the company said Tuesday. The pharmaceuticals maker will apply to the US Food and Drug Administration in June for approval to administer its vaccine to teenagers.

The Pfizer vaccine has already been approved for use in teenagers. 

More than 121 million doses of Moderna's vaccine had been administered in the US as of Monday, according to data from the Centers for Disease Control and Prevention, and nearly 53 million people have been fully vaccinated with it.

See also: COVID-19 vaccine side effects: What's normal and what to look out for

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.